Skip to main content
SpringerLink
Log in

Pharmacodynamic Properties of Felodipine

  • Section 1: Pharmacology and Human Pharmacokinetics of Felodipine
  • Published:
Drugs Aims and scope Submit manuscript

Summary

This overview presents the pharmacodynamic properties of felodipine as studied in animal experiments with emphasis on results from our laboratory.

Felodipine is 100-fold more potent in causing inhibition of spontaneously active vascular smooth muscle than myocardium in vitro. This vascular selectivity is significantly greater than that of nifedipine (potency ratio 15). Verapamil, D-600, La 3+ and reduction of [Ca 2+] o lack selectivity. The cellular mechanisms underlying this variable selectivity are not clear at present.

In conscious spontaneously hypertensive rats (SHR), the plasma concentration required for 20% reduction of mean arterial pressure is approximately 10 nmol. Mean arterial pressure is lowered dose-dependently as a result of reduced peripheral vascular resistance accompanied by increased cardiac output due to transient tachycardia and increased stroke volume. There was rapid resetting of the baroreflex set point but unaltered sensitivity after felodipine and hydralazine in SHR. Therefore, the reflexogenic increase in heart rate and plasma renin activity subsided within 3 to 5 hours of continuous felodipine administration in SHR. In addition, there was a uniform dilatation of the peripheral vascular beds after felodipine administration. During long term treatment of SHR with felodipine, progression of left ventricular and vascular wall hypertrophy was prevented.

Within the ‘therapeutic dose range’, the only primary effect observed in addition to arterial vasodilatation is diuresis/natriuresis caused by a renal tubular action.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Bolton TB. Mechanisms of action of transmitters and other substances on smooth muscle. Physiological Review 59: 606–718, 1979

    CAS  Google Scholar 

  • Boström S-L, Ljung B, Nordlander M, Johansson B. Actions of felodipine in vascular smooth muscle. In Hidaka and Hartshorne (Eds) Calmodulin: antagonists and cellular function, pp. 273–286. Academic Press, London, 1985

    Google Scholar 

  • DiBona GF, Sawin LL. Renal tubular site of action of felodipine. Journal of Pharmacology and Experimental Therapeutics 228: 420–424, 1984

    PubMed  CAS  Google Scholar 

  • DiBona G. Effects of felodipine on renal function in animals. Drugs 29(Suppl. 2): 168–175, 1985

    Article  PubMed  Google Scholar 

  • Ek B, Sjölander M, DiBona GF, Hallbäck-Nordlander M, Ljung B. The effect of felodipine on renal hemodynamics and excretion in the dog. Proceedings of the Society for Biology and Medicine 179: 201–205, 1985

    CAS  Google Scholar 

  • Fleckenstein A. Calcium antagonism in heart and smooth muscle. Experimental facts and therapeutic prospects. John Wiley & Sons Inc, New York, 1982

    Google Scholar 

  • Fleckenstein-Grün G, Makita Y, Byon YK, Fleckenstein A. Effects of Ca++-agonistic and Ca++-antagonistic 1,4-dihydropyridine compounds on tonic and phasic activation of extramural coronary vasculature; Bayer-Symposium IX. Cardiovascular effects of dihydropyridine-type. Calcium antagonists and agonists, pp. 290–305, Springer-Verlag, Berlin, 1985

    Chapter  Google Scholar 

  • Folkow B. Description of the myogenic hypothesis. Circulation Research 15(Suppl. 1): 279–285, 1964

    PubMed  Google Scholar 

  • Folkow B, Hallbäck M, Jones JV, Sutter M. Dependence on external calcium for the noradrenaline contractility of the resistance vessels in spontaneously hypertensive and renal hypertensive rats, as compared with normotensive controls. Acta Physiologica Scandinavica 101: 84–97, 1977

    Article  PubMed  CAS  Google Scholar 

  • Folkow B, Hallbäck M, Lundgren Y, Weiss L. Background of increased flow resistance and vascular reactivity in spontaneously hypertensive rats. Acta Physiologica Scandinavica 80: 93–106, 1970

    Article  PubMed  CAS  Google Scholar 

  • Gustafsson D. Microvascular mechanisms involved in calcium antagonist oedema formation. Journal of Cardiovascular Pharmacology, in press, 1987

    Google Scholar 

  • Johansson B, Jonsson O, Axelsson J, Wahlström B. Electrical and mechanical characteristics of vascular smooth muscle response to norepinephrine and isoproterenol. Circulation Research 21: 619–633, 1967

    Article  PubMed  CAS  Google Scholar 

  • Johnson JD. A calmodulin-like Ca2+ receptor in the Ca2+-channel. Biophysiological Journal 45: 134–136, 1984

    Article  CAS  Google Scholar 

  • Ljung B, Stage L. Adrenergic excitatory influences on rat portal vein. Acta Physiologica Scandinavica 80: 131–141, 1970

    Article  PubMed  CAS  Google Scholar 

  • Ljung B. Vascular versus myocardial selectivity in vitro of H 154/82, a new dihydropyridine. Blood Vessels (Abstract) 17: 154, 1980

    Google Scholar 

  • Ljung B. Vascular selectivity of felodipine. Drugs 29(Suppl. 2): 46–58, 1985

    Article  PubMed  Google Scholar 

  • Ljung B, Ahnoff M, Boström S-L, Kjellstedt A, Sjöqvist A. Effects of felodipine on electrical and mechanical activity in portal vein. 8th Congress of Pharmacologists, Tokyo, Abstract no. 43, p.247, 1981

  • Ljung B, Kjellstedt A. Functional antagonism of noradrenaline responses by felodipine and other calcium antagonists in vascular smooth muscles. Journal of Cardiovascular Pharmacology 10(Suppl. 1): S82–S88, 1987

    Article  PubMed  CAS  Google Scholar 

  • Ljung B, Kjellstedt A, Orebäck B. Vascular versus myocardial selectivity of calcium antagonists studied by concentration-time-effect relations. Journal of Cardiovascular Pharmacology 10(Suppl. 1): S34–S39, 1987a

    Article  PubMed  CAS  Google Scholar 

  • Ljung B, Nordlander M, Johansson B. Felodipine sensitivity in vivo and in vitro of activation pathways in vascular smooth muscles. Journal of Cardiovascular Pharmacology 10(Suppl. 1): S89–S95, 1987b

    Article  PubMed  CAS  Google Scholar 

  • Lundin S, Hallbäck-Nordlander M. Regression of structural cardiovascular changes by antihypertensive therapy in spontaneously hypertensive rats. Journal of Hypertension 2: 11–18, 1984

    Article  PubMed  CAS  Google Scholar 

  • Muir AL, Wathen CO, Hannan WJ. Effects of felodipine on resistance and capacitance vessels in patients with essential hypertension. Drugs 29(Suppl. 2): 59–65, 1985

    Article  PubMed  Google Scholar 

  • Nordlander, M. Haemodynamic effects of short and long term administration of felodipine in spontaneously hypertensive rats. Drugs 29(Suppl. 2): 90–101, 1985

    Article  PubMed  Google Scholar 

  • Nordlander M, DiBona GF, Ljung B, Yao T, Thorén P. Renal and cardiovascular effects of acute and chronic administration of felodipine to SHR. European Journal of Pharmacology 113: 25–36, 1985

    Article  PubMed  CAS  Google Scholar 

  • Nordlander M, Horton R, Thalén P. Baroreflex control of renin release in spontaneously hypertensive rats after administration of felodipine. Drugs 34(Suppl. 3): 53–56, 1987

    Article  PubMed  CAS  Google Scholar 

  • Nyborg NCB, Mulvany MJ. Effect of felodipine, a new dihydropyridine vasodilator, on contractile responses to potassium, noradrenaline, and calcium in mesenteric resistance vessels of the rat. Journal of Cardiovascular Pharmacology 6: 499–505, 1984

    Article  PubMed  CAS  Google Scholar 

  • Somlyo AP, Somlyo AV. Vascular smooth muscle. II. Pharmacology of normal and hypertensive vessels. Pharmacological Review 22: 249–253, 1970

    CAS  Google Scholar 

  • Sutter MC, Ljung B. Contractility, muscle mass and agonist sensitivity of isolated portal veins from normo- and hypertensive rats. Acta Physiologica Scandinavica 99: 484–495, 1977

    Article  PubMed  CAS  Google Scholar 

  • Vogel HJ. Ligand Binding Sites on Calmodulin; in Weiss (Ed.) Calcium in Drug Action, Plenum Press, New York, in press

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacology and Biochemistry, Hässle Cardiovascular Research Laboratories, Mölndal, Sweden

    Bengt Ljung & M. Nordlander

Authors
  1. Bengt Ljung
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Nordlander
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ljung, B., Nordlander, M. Pharmacodynamic Properties of Felodipine. Drugs 34 (Suppl 3), 7–15 (1987). https://doi.org/10.2165/00003495-198700343-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-198700343-00004

Keywords

Search

Navigation